FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to anesthesiology and resuscitation, and can be used for prediction of cardiovascular complications of spinal anesthesia in oncological patients. Random limit apnea (RLA) duration is determined in patient by duration of maximum breath taking after deep breath. If RLA is less or equal to 32 seconds, high risk of cardiovascular complications of spinal anaesthesia is detected. If RLA is more than 32 seconds low risk of cardiovascular complications is detected.
EFFECT: method enables non-invasive, simple, high sensitive and specific assessing of functional state of cardiorespiratory system by determining RLA duration.
1 cl, 3 ex
Authors
Dates
2017-01-30—Published
2015-10-23—Filed